Repligen | RGEN - Market Capitalization

Stock Price
117.60
Daily Change
3.54 3.10%
Monthly
2.87%
Yearly
-18.76%
Q2 Forecast
115.08

Repligen reported $6.36B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 37.86B 3.64B Dec/2025
Align Technology USD 11.2B 2.13B Dec/2025
Bio Techne USD 9.16B 502M Dec/2025
BioMarin Pharmaceutical USD 11.42B 1.02B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Bruker USD 7.16B 2.23B Dec/2025
Charles River Laboratories USD 10.02B 2.71B Dec/2025
Danaher USD 140.45B 11.98B Apr/2026
Dentsply International USD 2.28B 251M Dec/2025
General Electric Aerospace USD 310.34B 13.85B Apr/2026
Henry Schein USD 8.96B 951M Dec/2025
Illumina USD 20.62B 6.53B Dec/2025
IQVIA Holdings USD 29.18B 9.2B Apr/2026
Mettler Toledo International USD 28.48B 3.19B Dec/2025
Myriad Genetics USD 575M 98M Dec/2025
OraSure Technologies USD 174M 61M Dec/2025
Pacific Biosciences Of California USD 565M 180M Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Repligen USD 9.22B 1.7B Dec/2025
Revvity USD 10.97B 1.21B Dec/2025
Standard Biotools USD 492M 5M Dec/2025
Thermo Fisher Scientific USD 177.96B 4.7B Apr/2026
Waters USD 22.61B 5.25B Dec/2025
West Pharmaceutical Services USD 22.67B 4.61B Apr/2026